Mercer Global Advisors
ONC

Mercer Global Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Mercer Global Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+394
New +$116K ﹤0.01% 3739

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Mercer Global Advisors's ONC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 394 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #3739 among its holdings.

273 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Mercer Global Advisors held 394 shares of BeOne Medicines Ltd worth $112K as of Q2 2026.
  • BeOne Medicines Ltd was a new Mercer Global Advisors position in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3739 holding.
  • 273 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.